SPONSOR
OX2 Therapeutics
Total Trials
1
Recruiting
1
Phases
Phase 1
OX2 Therapeutics is a clinical research sponsor with 1 registered studies on ClinicalTrials.gov, of which 1 are actively recruiting participants. Research covers conditions including Diffuse Midline Glioma, H3 K27M-Mutant, Recurrent High Grade Glioma.
The trial portfolio spans Phase 1 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — OX2 Therapeutics
How many clinical trials has OX2 Therapeutics sponsored?
ClinicalMetric currently tracks 1 clinical trials sponsored by OX2 Therapeutics, of which 1 are actively recruiting participants. These trials cover conditions including Diffuse Midline Glioma, H3 K27M-Mutant, Recurrent High Grade Glioma. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does OX2 Therapeutics research focus on?
OX2 Therapeutics clinical trials span Diffuse Midline Glioma, H3 K27M-Mutant, Recurrent High Grade Glioma. The research pipeline includes Phase 1 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a OX2 Therapeutics clinical trial?
To participate in a OX2 Therapeutics trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all OX2 Therapeutics trials with current recruitment status updated daily.
Clinical Trials by OX2 Therapeutics
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology